Exom Deutschland GmbH (Exom Group Srl)

Exom is the expert digital full-service CRO committed to the modernization of clinical trials through implementation of innovative digital solutions. By combining our expertise in managing clinical trials with our proprietary, multi-modular and cloud-based platform Genius SUITE™, Exom improves efficiencies and escalate process speeds while ensuring data quality and cost reduction, from phase I-IV. Our international network qualified Partners (Exom Alliance), trained to Exom’s technologies and processes, provides an established organization, active across the whole of Europe and North America. Our mission is to innovate clinical research with passion, integrity, transparency, caring and innovation.

https://www.linkedin.com/company/exom-group/

  • Mitarbeiterzahl

    40
  • Ausrichtungen
    • Auftragsforschung
  • Gegründet

    2016
  • Aktualisiert am

    09.09.2019

Exom - proud winner of the Business Excellence Award 2019“

Exom Group is pleased to announce that it received the Business Excellence Award 2019.


The Prize, promoted by the Harvard Business Review and the Italian Stock Exchange, is awarded to companies operating in Italy that have distinguished themselves with their outstanding performance in 2019. The reward honors the capacity for innovation, internationalization, growth, and management of human resources and talent.

Dr. Luigi Visani, CEO & President of Exom Group

Exom named Finalist of the SCRIP AWARDS 2019 in “Best Technological Development in Clinical Trials”

Exom Group, the Global Digital Full-Service CRO, proudly announces that its digital platform Genius ROSA has been nominated Finalist of the Scrip Awards 2019 edition for the category “Best Technological Development in Clinical Trials”. “This nomination confirms the value of Exom’s innovative strategy in implementing novel digital solutions into clinical trials, to better satisfy the industry expectations”, says Luigi Visani MD, President & CEO of Exom Group.